Evidence map›Paper›PMID 25353184›Full record

ArticleEndocrinology2015

Functional zebrafish studies based on human genotyping point to netrin-1 as a link between aberrant cardiovascular development and thyroid dysgenesis.

Robert Opitz, Marc-Philip Hitz, Isabelle Vandernoot, Achim Trubiroha, Rasha Abu-Khudir, Mark Samuels, Valérie Désilets, Sabine Costagliola, Gregor Andelfinger, Johnny Deladoëy

Open access · bronzeAbstract read
In one paragraph

Article in Endocrinology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 56 citations in OpenAlex.

  1. Guideline
  2. Approach to the patient: genetics and management of congenital hypothyroidism.The Journal of clinical endocrinology and metabolism · 2026
    Article
  3. Article
  4. Expression of Netrin-1 in the developing mouse heart.Gene expression patterns : GEP · 2025
    Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Whole-Exome Sequencing in Congenital Hypothyroidism Due to Thyroid Dysgenesis.Thyroid : official journal of the American Thyroid Association · 2022
    Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Robert OpitzInstitute of Interdisciplinary Research in Molecular Human Biology (R.O., I.V., A.T., S.C.), Université Libre de Bruxelles, 1070 Brussels, Belgium; Research Center of Centre Hospitalier Universitaire Sainte-Justine (M.-P.H., I.V., R.A.-K., M.S., G.A., J.D.), Department of Pediatrics, Université de Montréal, Montréal, Québec, Canada H3T 1C5; and Department of Medical Genetics (V.D.), Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Canada J1H 1P8.
Marc-Philip Hitz
Isabelle Vandernoot
Achim Trubiroha
Rasha Abu-Khudir
Mark Samuels
Valérie Désilets
Sabine Costagliola
Gregor Andelfinger
Johnny Deladoëy
Centre Hospitalier Universitaire Sainte-Justine · CAUniversité Libre de Bruxelles · BECentre Hospitalier Universitaire de Sherbrooke · CAUniversité de Montréal · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Congenital hypothyroidism caused by thyroid dysgenesis (CHTD) is a common congenital disorder with a birth prevalence of 1 case in 4000 live births, and up to 8% of individuals with CHTD have co-occurring congenital heart disease. Initially we found nine patients with cardiac and thyroid congenital disorders in our cohort of 158 CHTD patients. To enrich for a rare phenotype likely to be genetically simpler, we selected three patients with a ventricular septal defect for molecular studies. Then, to assess whether rare de novo copy number variants and coding mutations in candidate genes are a source of genetic susceptibility, we used a genome-wide single-nucleotide polymorphism array and Sanger sequencing to analyze blood DNA samples from selected patients with co-occurring CHTD a congenital heart disease. We found rare variants in all three patients, and we selected Netrin-1 as the biologically most plausible contributory factor for functional studies. In zebrafish, ntn1a and ntn1b were not expressed in thyroid tissue, but ntn1a was expressed in pharyngeal arch mesenchyme, and ntn1a-deficient embryos displayed defective aortic arch artery formation and abnormal thyroid morphogenesis. The functional activity of the thyroid in ntn1a-deficient larvae was, however, preserved. Phenotypic analysis of affected zebrafish indicates that abnormal thyroid morphogenesis resulted from a lack of proper guidance exerted by the dysplastic vasculature of ntn1a-deficient embryos. Hence, careful phenotyping of patients combined with molecular and functional studies in zebrafish identify Netrin-1 as a potential shared genetic factor for cardiac and thyroid congenital defects.

Indexed as

GenotypeAnimalsAnimals, Genetically ModifiedCardiovascular AbnormalitiesFemaleGene Expression Regulation, DevelopmentalGene Knockdown TechniquesGenetic Predisposition to DiseaseHumansMaleMorpholinosNerve Growth FactorsNetrin-1Polymorphism, Single NucleotideRNA, MessengerSynaptotagminsMorpholinosNerve Growth FactorsNetrin-1ntn1a protein, zebrafishNTN1 protein, humanRNA, MessengerSynaptotagminsSYT17 protein, humanTumor Suppressor ProteinsZebrafish Proteins

Identifiers

PMID25353184
PMCPMC4272402
OpenAlexW2078880308

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.